Ishigami M - Search Results

1

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.

Huang DQ, Tran A, Yeh ML, Yasuda S, Tsai PC, Huang CF, Dai CY, Ogawa E, Ishigami M, Ito T, Kozuka R, Enomoto M, Suzuki T, Yoshimaru Y, Preda CM, Marin RI, Sandra I, Tran S, Quek SXZ, Khine HHTW, Itokawa N, Atsukawa M, Uojima H, Watanabe T, Takahashi H, Inoue K, Maeda M, Hoang JK, Trinh L, Barnett S, Cheung R, Lim SG, Trinh HN, Chuang WL, Tanaka Y, Toyoda H, Yu ML, Nguyen MH. Huang DQ, et al. Among authors: ishigami m. Hepatology. 2023 Nov 1;78(5):1558-1568. doi: 10.1097/HEP.0000000000000459. Epub 2023 May 16. Hepatology. 2023. PMID: 37184202

2

Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C.

Shinohara E, Yamashita S, Kihara S, Hirano K, Ishigami M, Arai T, Nozaki S, Kameda-Takemura K, Kawata S, Matsuzawa Y. Shinohara E, et al. Among authors: ishigami m. Hepatology. 1997 Jun;25(6):1502-6. doi: 10.1002/hep.510250632. Hepatology. 1997. PMID: 9185775 Clinical Trial.

3

The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice.

Ishigami M, Nishimura H, Naiki Y, Yoshioka K, Kawano T, Tanaka Y, Taniguchi M, Kakumu S, Yoshikai Y. Ishigami M, et al. Hepatology. 1999 Jun;29(6):1799-808. doi: 10.1002/hep.510290605. Hepatology. 1999. PMID: 10347123

4

Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.

Hayashi K, Katano Y, Takeda Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yano M, Goto H, Yoshioka K, Toyoda H, Kumada T. Hayashi K, et al. Among authors: ishigami m. J Med Virol. 2007 Apr;79(4):366-73. doi: 10.1002/jmv.20824. J Med Virol. 2007. PMID: 17311332

5

Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.

Honda T, Katano Y, Urano F, Murayama M, Hayashi K, Ishigami M, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Honda T, et al. Among authors: ishigami m. J Gastroenterol Hepatol. 2007 Jul;22(7):989-95. doi: 10.1111/j.1440-1746.2006.04773.x. J Gastroenterol Hepatol. 2007. PMID: 17608843

6

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.

Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H. Kuzuya T, et al. Among authors: ishigami m. J Gastroenterol Hepatol. 2007 Nov;22(11):1929-35. doi: 10.1111/j.1440-1746.2006.04707.x. J Gastroenterol Hepatol. 2007. PMID: 17914972

7

Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis.

Hayashi K, Katano Y, Takeda Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishigami m. J Gastroenterol. 2008;43(7):558-64. doi: 10.1007/s00535-008-2197-2. Epub 2008 Jul 23. J Gastroenterol. 2008. PMID: 18648743

8

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy.

Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishigami m. J Med Virol. 2009 Mar;81(3):459-66. doi: 10.1002/jmv.21407. J Med Virol. 2009. PMID: 19152412

9

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

Honda T, Katano Y, Shimizu J, Ishizu Y, Doizaki M, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Honda T, et al. Among authors: ishigami m. Liver Int. 2010 Apr;30(4):527-37. doi: 10.1111/j.1478-3231.2009.02064.x. Epub 2009 Jun 12. Liver Int. 2010. PMID: 19523048

10

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.

Hayashi K, Katano Y, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yoshioka K, Yano M, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishigami m. J Gastroenterol Hepatol. 2010 Apr;25(4):745-9. doi: 10.1111/j.1440-1746.2009.06118.x. Epub 2010 Jan 13. J Gastroenterol Hepatol. 2010. PMID: 20074155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

479 results

Search Page